Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleRadiation Safety

Establishment of National Diagnostic Reference Levels for Administered Activity in Diagnostic Nuclear Medicine in Thailand

Dutsadee Suttho
Journal of Nuclear Medicine Technology April 2024, jnmt.123.266836; DOI: https://doi.org/10.2967/jnmt.123.266836
Dutsadee Suttho
Department of Radiological Technology, Faculty of Allied Health Sciences, Thammasat University, Khlong Nueng, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1.

    National Survey Results for Thailand

    Organ system and protocolRadiopharmaceuticalPatients (n)M/F (n)Age (y)Weight (kg)Activity (MBq)Modality
    Skeletal/marrow99mTc-MDP2,284882/1,40259.29 ± 15.8359.27 ± 13.51720.39 ± 98.79SPECT
    Cardiovascular
     MUGA99mTc-RBC31716/30153.61 ± 10.8758.62 ± 10.48752.21 ± 90.65SPECT, SPECT/CT
     MPI MIBI
      Rest99mTc-MIBI20597/10866.33 ± 10.9162.78 ± 15.75421.06 ± 204.61SPECT, SPECT/CT
      Stress21197/11465.92 ± 11.2462.11 ± 14.0719.28 ± 303.40SPECT, SPECT/CT
     MPI 201Tl201Tl-chloride4030/1068.28 ± 9.8262.99 ± 15.5697.68 ± 25.16SPECT, SPECT/CT
    Pulmonary
     Perfusion99mTc-MAA4015/2564.09 ± 14.0259.41 ± 13.56227.55 ± 74.00SPECT, SPECT/CT
     Ventilation99mTc-DTPA aerosol2412/1162.65 ± 11.0566.65 ± 13.71916.49 ± 190.18SPECT, SPECT/CT
    99mTc-Technegas*662.30 ± 139.49SPECT, SPECT/CT
    Gastrointestinal
     Protein losing99mTc-HSA155/1051.16 ± 13.9155.48 ± 8.34609.02 ± 186.48SPECT, SPECT/CT
     Hepatobiliary99mTc-IDA128/464.59 ± 21.6567.32 ± 16.60237.17 ± 66.97SPECT, SPECT/CT
     Esophagus99mTc-phytate203/1751.5 ± 11.4354.56 ± 8.9431.45 ± 1.11SPECT
     Gastric emptying99mTc-phytate (solid meal)227/1551.52 ± 19.7958.28 ± 6.5238.85 ± 5.92SPECT
     GI bleeding99mTc-RBC139/464.82 ± 14.9156.64 ± 8.42490.99 ± 199.06SPECT, SPECT/CT
     Hemangiomas99mTc-pertechnetate103/750.49 ± 20.6457.79 ± 6.71214.97 ± 91.02SPECT, SPECT/CT
    Genitourinary99mTc-MAG39958/4247.76 ± 15.5161.42 ± 13.41134.31 ± 75.85SPECT
    99mTc-DTPA4925/2449.98 ± 16.0663.98 ± 15.94156.51 ± 136.53SPECT
    Oncology131I-sodium iodide9914/8546.42 ± 13.6863.83 ± 14.2495.83 ± 33.67SPECT, SPECT/CT
    131I-MIBG215/1648.25 ± 15.9861.29 ± 13.4944.77 ± 9.25SPECT, SPECT/CT
    67Ga-citrate354/228.98 ± 11.8155.0 ± 10.31158.73 ± 22.57SPECT, SPECT/CT
    99mTc-MIBI298/2249.02 ± 16.5462.62 ± 13.87731.49 ± 78.07SPECT, SPECT/CT
    18F-FDG19692/10459.63 ± 14.8059.84 ± 11.98324.12 ± 83.62PET/CT
    18F-PSMA1515/068.64 ± 5.1462.74 ± 0.61242.72 ± 22.57PET/CT
    68Ga-PSMA1717/070.62 ± 10.5470.03 ± 10.58187.96 ± 44.03PET/CT
    Lymphatic99mTc-dextran203/1757.49 ± 12.0976.62 ± 22.6196.20 ± 24.79SPECT
    99mTc-nanocolloid310/3158.07 ± 12.23NA16.65 ± 10.73SPECT, SPECT/CT
    Endocrine
     Thyroid99mTc-pertechnetate33254/27849.22 ± 15.3360.77 ± 12.43120.25 ± 39.22SPECT
    131I-sodium iodide20128/17347.33 ± 14.6661.32 ± 13.25122.10 ± 82.88SPECT
     Parathyroid99mTc-pertechnetate7229/4351.46 ± 15.7557.99 ± 13.81155.03 ± 117.66SPECT, SPECT/CT
    99mTc-MIBI10642/6451.96 ± 15.6058.33 ± 14.54709.29 ± 121.73SPECT, SPECT/CT
    Nervous system18F-FDG189/971.66 ± 10.7256.58 ± 8.26251.23 ± 35.52PET/CT
    Infection/ inflammation67Ga-citrate85/346.87 ± 17.4143.03 ± 8.39186.85 ± 19.98SPECT/CT
    99mTc-SC-WBC95/467.55 ± 14.0448.0728.90 ± 71.78SPECT
    • ↵* Cyclomedica.

    • MDP = methylene diphosphonate; MUGA = multigated acquisition; RBC = red blood cells; MPI = myocardial perfusion imaging; MIBI = methoxyisobutylisonitrile; MAA = macroaggregated albumin; DTPA = diethylenetriaminepentaacetic acid; HSA = human serum albumin; IDA = iminodiacetic acid; GI = gastrointestinal; MAG3 = mercaptoacetyltriglycine; NA = not applicable; PSMA = prostate-specific membrane antigen; SC-WBC = sulfur colloid white blood cells.

    • Age, weight, and activity are expressed as mean ± SD.

    • View popup
    TABLE 2.

    NDRLs for Most Common Procedures in Thailand

    Percentile of dose distribution
    Organ system and protocolRadiopharmaceuticalMean activity ± SD (MBq)25th50th75thMeanNDRL (MBq)
    Skeletal/marrow99mTc-MDP720.39 ± 98.79680.80747.03773.30720.39773.3
    Cardiovascular
     MUGA99mTc-RBC752.21 ± 90.65715.58740.00795.50752.21795.5
     MPI MIBI
      Rest99mTc-MIBI421.06 ± 204.61273.80310.80658.60421.06658.6
      Stress99mTc-MIBI719.28 ± 303.40305.25740.00947.2719.28947.2
     MPI 201Tl201Tl-chloride97.68 ± 25.1692.5099.90115.8197.68115.81
    Pulmonary
     Perfusion99mTc-MAA227.55 ± 74.00185.00214.60240.5227.55240.5
     Ventilation99mTc-DTPA aerosol916.49 ± 190.18784.4888.001110916.491110
    99mTc-Technegas*662.30 ± 139.49545.38678.58752.95662.30752.95
    Gastrointestinal
     Protein losing99mTc-HSA609.02 ± 186.48408.48632.70723.35609.02723.35
     Hepatobiliary99mTc-IDA237.17 ± 66.97195.36214.23235.69237.17235.69
     Esophagus99mTc-phytate (esophagus)31.45 ± 1.1130.7131.4531.4531.4531.45
     Gastric emptying99mTc-phytate (solid meal)38.85 ± 5.9237.3739.2240.738.8540.7
     GI bleeding99mTc-RBC490.99 ± 199.06307.84451.77677.1488.40677.1
     Hemangiomas99mTc-pertechnetate214.97 ± 91.02185.00185.00186.48214.97186.48
    Genitourinary99mTc-MAG3134.31 ± 75.85108.41118.40134.31134.41134.31
    99mTc-DTPA156.51 ± 136.5366.60185.00185156.51185
    Oncology131I-sodium iodide95.83 ± 33.6774.0074.0011195.83111
    131I-MIBG44.77 ± 9.2538.4842.5546.6244.7746.62
    67Ga-citrate158.73 ± 22.57144.30144.67174.64158.73174.64
    99mTc-MIBI731.49 ± 78.07740.00754.80784.4731.49784.4
    18F-FDG324.12 ± 83.62268.62320.42376.29324.12376.29
    18F-PSMA242.72 ± 22.57223.48237.91263.81242.72263.81
    68Ga-PSMA187.96 ± 44.03150.59190.55209.05187.96209.05
    Lymphatic99mTc-dextran96.20 ± 24.7979.1890.65103.696.20103.6
    99mTc-nanocolloid16.65 ± 10.7314.8014.8014.816.6514.8
    Endocrine
     Thyroid99mTc-pertechnetate120.25 ± 39.2291.02109.52140.6120.25140.6
     131I-sodium iodide122.1 ± 82.8874.00111.00185122.10185
     Parathyroid99mTc-pertechnetate155.03 ± 117.66106.19130.98166.5155.03166.5
    99mTc-MIBI709.29 ± 121.73604.58740.00794.76709.29794.76
    Nervous system18F-FDG251.23 ± 35.52223.48251.23268.25251.23268.25
    Infection/inflammation67Ga-citrate186.85 ± 19.9849.58186.11192.4186.85192.4
    99mTc-SC-WBC728.9 ± 71.78736.3740.00765.9728.9765.9
    • ↵* Cyclomedica.

    • MDP = methylene diphosphonate; MUGA = multigated acquisition; RBC = red blood cells; MPI = myocardial perfusion imaging; MIBI = methoxyisobutylisonitrile; MAA = macroaggregated albumin; DTPA = diethylenetriaminepentaacetic acid; HSA = human serum albumin; IDA = iminodiacetic acid; GI = gastrointestinal; MAG3 = mercaptoacetyltriglycine; PSMA = prostate-specific membrane antigen; SC-WBC = sulfur colloid white blood cells.

    • View popup
    TABLE 3.

    NDRLs for Thailand Compared with Other Countries

    Organ system and protocolRadiopharmaceuticalThailandJapanKoreaAustraliaKuwaitU.K.United StatesEuropean Union
    Skeletal/marrow99mTc-MDP773.3950925920944600848–1,185500–1,110
    Cardiovascular
     MUGA99mTc-RBC795.5—7401,030740800916–1,301600–1,000
     MPI MIBI
      Rest99mTc-MIBI658.6900555620976800519–1,153560
      Stress947.21,2001,1101,520976800945–1,4021,100
     MPI 201Tl201Tl-chloride115.81180111120—80—75–150
    Pulmonary (perfusion)99mTc-MAA240.5260222240217.5100147–226100–296
    Gastrointestinal
     Hepatobiliary99mTc-IDA235.69—370210—150——
     Gastric emptying99mTc-phytate (solid meal)40.7—11144371231–50150–540
    Genitourinary99mTc-MAG3134.31400500305370100283–379100–370
    99mTc-DTPA18540055550090300407–587—
    Oncology131I-sodium iodide111—185185—400—90–400
    18F-FDG376.29240370310230400461–710200–400
    Endocrine
     Thyroid99mTc-pertechnetate140.630021721518580—75–222
     131I-sodium iodide185—185185200400—90–400
     Parathyroid99mTc-MIBI794.76800740900900900—400–900
    Nervous system18F-FDG268.25240370250231250——
    Infection/inflammation99mTc-SC-WBC765.9—888800892.5200—300–600
    • MDP = methylene diphosphonate; MUGA = multigated acquisition; RBC = red blood cells; MPI = myocardial perfusion imaging; MIBI = methoxyisobutylisonitrile; MAA = macroaggregated albumin; IDA = iminodiacetic acid; MAG3 = mercaptoacetyltriglycine; SC-WBC = sulfur colloid white blood cells.

    • Data are megabecquerels.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Establishment of National Diagnostic Reference Levels for Administered Activity in Diagnostic Nuclear Medicine in Thailand
Dutsadee Suttho
Journal of Nuclear Medicine Technology Apr 2024, jnmt.123.266836; DOI: 10.2967/jnmt.123.266836
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Diagnostic Reference Levels in PET Imaging at Chulabhorn Hospital, Thailand
  • Experiences of Nuclear Medicine Technologists Working in PET/CT Facilities in Gauteng Province, South Africa
Show more RADIATION SAFETY

Similar Articles

Keywords

  • diagnostic reference level
  • DRL
  • nuclear medicine
  • radiation protection
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Establishment of National Diagnostic Reference Levels for Administered Activity in Diagnostic Nuclear Medicine in Thailand
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Establishment of National Diagnostic Reference Levels for Administered Activity in Diagnostic Nuclear Medicine in Thailand
Dutsadee Suttho
Journal of Nuclear Medicine Technology Apr 2024, jnmt.123.266836; DOI: 10.2967/jnmt.123.266836

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.